[Elsevier] Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study |
|
This post will be closed automatically in 2026-07-02 23:37
Best Answer
Yesterday 23:38
|
| |
10
Effects of melatonin supplementation on diabetes: A systematic review and meta-analysis of randomized clinical trials
10
Antimicrobial Stewardship in the Intensive Care Unit
30
Fetal Head and Neck Imaging
20
Clinical Practice Guideline for Spontaneous Isolated Superior Mesenteric Artery Dissection (2025 Edition)
10
Ethical, legal, and regulatory perspectives in computational drug design
